enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

3. Does Medicare Part B cover Rituxan infusions? - AOL

   www.aol.com/does-medicare-part-b-cover-010000603...

   Medicare Part B (medical insurance) may cover Rituxan (rituximab) infusions. This is because medical professionals typically administer the medication in a medical setting on an outpatient basis.

4. EPOCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/EPOCH_(chemotherapy)

   IV continuous infusion over 24 h Days 1–4 This regimen requires the use of prophylactic antibiotics to prevent infectious complications, as well as the use of colony-stimulating factors (G-CSF) from the first day after the end of chemotherapy to the day of full blood count restoration ( ANC > 1000/μL).

5. Intracardiac injection - Wikipedia

   en.wikipedia.org/wiki/Intracardiac_injection

   The practice of intracardiac injection originated in the 1800s. It was commonly performed during the 1960s, as it was considered the fastest way to get medication to the heart. The practice began declining during the 1970s as more reliable delivery methods (i.e., intravenous, endotracheal, and intraosseous) came into use. Around that time ...

6. Cytokine release syndrome - Wikipedia

   en.wikipedia.org/wiki/Cytokine_release_syndrome

   The most predictive biomarkers 36h after CAR-T infusion of CRS are a fever ≥38.9 °C (102 °F) and elevated levels of MCP-1 in serum. [12] Many of the cytokines elevated in CRS are not produced by CAR-T cells, but by myeloid cells that are pathogenically licensed through T-cell-mediated activating mechanisms.

7. Mom Begs Doctors to Treat Sick Newborn. 3 Months Later, a ...

   www.aol.com/mom-begs-doctors-treat-sick...

   The most effective measures only briefly improved Violette's condition. Within hours, she'd resume wailing and vomiting excessively. At 5 weeks old, her pediatrician urgently referred the family ...

8. Specialty drugs in the United States - Wikipedia

   en.wikipedia.org/wiki/Specialty_drugs_in_the...

   In 2010 the United States enacted a new health law which had unintended consequences. Because of the 2010 law, drug companies like Genentech informed children's hospitals that they would no longer get discounts for certain cancer medicines such as the orphan drugs Avastin, Herceptin, Rituxan, Tarceva, or Activase. This cost hospitals millions ...

9. Hegseth orders immediate pause on gender-affirming medical ...

   www.aol.com/hegseth-orders-immediate-pause...

   Defense Secretary Pete Hegseth ordered an immediate pause on gender-affirming medical care procedures for all active-duty service members in a memo that was addressed to senior Pentagon leadership ...